BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 24.61%57.96M | ---- | -20.95%46.52M | 26.64%30.65M | 153.19%58.84M | 159.70%24.2M | 163.33%23.24M | -250.63%-40.53M | -136.06%-36.7M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | ---- | -69.28%-10.28M | 0.54%-13.33M | -39.86%-6.07M | -18.73%-13.41M | 16.67%-4.34M | 17.84%-11.29M |
Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | 6.42%-1.87M | ---- | -13.80%-2M | ---- | -4.35%-1.75M |
Investment loss (gain) | ---- | 290.68%1.24M | ---- | ---650.06K | ---- | ---- | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | 6.37%1.67M | 27.33%2.31M | -5.02%1.57M | 375.65%1.81M | 81.36%1.65M | 88.95%-657K |
Impairment and provisions: | ---- | -135.60%-6.43M | ---- | 753.93%18.05M | 285.86%5.48M | 20.30%-2.76M | 9.87%-2.95M | -118.17%-3.46M | -13.41%-3.27M | 1,561.50%19.06M |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | 23.33%-230K | ---- | ---300K | --300K |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | 437.67%4.23M | -395.74%-24.08M | 57.85%-1.25M | -125.90%-4.86M | -3.01%-2.97M | 381.74%18.76M |
-Other impairments and provisions | ---- | -153.64%-7.61M | ---- | -33.50%14.18M | 185.34%1.25M | 1,428.53%21.32M | ---1.47M | --1.4M | ---- | ---- |
Asset sale loss (gain): | ---- | 26.64%-282.78K | ---- | 90.97%-385.46K | -608.26%-1.63M | -765.52%-4.27M | 83.47%-230K | 93.91%-493K | 19.08%-1.39M | -4,725.14%-8.09M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---2K | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 26.64%-282.78K | ---- | 90.96%-385.46K | -608.26%-1.63M | -765.11%-4.27M | 83.47%-230K | 93.91%-493K | 19.08%-1.39M | -4,725.14%-8.09M |
Depreciation and amortization: | ---- | 67.24%102.77M | ---- | -56.80%61.45M | 0.52%61.85M | -6.04%142.26M | -14.23%61.53M | 10.27%151.4M | 6.48%71.73M | 18.04%137.3M |
-Amortization of intangible assets | ---- | 28.65%29.78M | ---- | 36.03%23.15M | -22.87%6.92M | -24.02%17.02M | -1.69%8.98M | 22.97%22.39M | 5.74%9.13M | 11.28%18.21M |
-Other depreciation and amortization | ---- | 68.04%1.53M | ---- | --910.59K | ---- | ---- | ---- | ---- | ---- | ---- |
Financial expense | ---- | 3,794.19%9.55M | ---- | -96.99%245.17K | 35.84%3.38M | 29.37%8.14M | -34.72%2.49M | -25.98%6.29M | 10.39%3.81M | 371.44%8.5M |
Unrealized exchange loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,005.15%-1.07M | ---- | 70.78%-97K |
Special items | ---- | ---- | ---- | ---- | -913.16%-1.93M | -7.24%-12.78M | 93.04%-190K | -85.22%-11.92M | -10.25%-2.73M | -870.44%-6.43M |
Operating profit before the change of operating capital | ---- | ---- | ---- | ---- | 11.02%89.2M | 17.38%176.55M | 222.25%80.35M | 50.65%150.4M | -71.13%24.93M | -49.17%99.84M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 34.07%-10.35M | ---- | -19,980.34%-15.71M | -260.33%-10.86M | -99.01%79K | -143.15%-3.02M | 25.41%7.98M | -0.24%6.99M | -67.48%6.36M |
Accounts receivable (increase)decrease | ---- | 31.09%-631.87M | ---- | -528.90%-916.94M | 54.56%-99.27M | 133.19%213.79M | -180.13%-218.44M | -270.36%-644.22M | 591.45%272.61M | -169.78%-173.94M |
Accounts payable increase (decrease) | ---- | -28.85%570.72M | ---- | 366.71%802.1M | 421.64%138.06M | -163.04%-300.74M | 115.65%26.47M | -563.23%-114.33M | 55.86%-169.17M | 107.60%24.68M |
prepayments (increase)decrease | ---- | ---- | ---- | ---- | 552.50%28.11M | 44.62%-44.85M | 78.09%-6.21M | -546.33%-80.98M | -37.26%-28.35M | 229.18%18.14M |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | 101.09%2.01M | --197.01M | -1,395.34%-184.05M | ---- | -140.93%-12.31M |
Adjustment items for working capital changes | ---- | ---- | ---- | ---- | --15.34M | ---- | ---- | --1.06B | ---- | ---- |
Cash from business operations | ---- | ---- | ---- | ---- | 113.00%162.21M | -75.91%46.84M | -31.67%76.16M | 622.21%194.41M | 141.42%111.45M | -123.81%-37.23M |
Other taxs | ---- | ---- | ---- | ---- | -19.28%-11.46M | -47.34%-7.55M | -242.37%-9.61M | 43.70%-5.12M | 69.84%-2.81M | 83.88%-9.1M |
Special items of business | ---- | 22.90%104.51M | ---- | --85.03M | ---15.34M | ---- | ---- | ---- | ---- | ---- |
Adjustment items of business operations | 5.10%336.8M | 1,852.51%93.31M | 1,989.25%320.45M | ---5.32M | --15.34M | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | 5.10%336.8M | 148.17%197.82M | 112.57%320.45M | 102.87%79.71M | 126.53%150.75M | -79.24%39.29M | -38.75%66.55M | 508.61%189.29M | 139.03%108.64M | -146.38%-46.33M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | ---- | ---- | ---- | --10.28M | -0.54%13.33M | ---- | 18.73%13.41M | -16.67%4.34M | -18.82%11.29M |
Dividend received - investment | ---- | 10.95%3.44M | ---- | 8.00%3.1M | ---- | -4.27%2.87M | ---- | 70.85%3M | --1M | 4.35%1.75M |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---5.65M | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | 456.32%2.73M | -53.27%820.75K | --490.63K | 117.64%1.76M | ---- | -49.75%807K | -94.35%399K | -84.55%1.61M | 44.81%7.06M | 3,913.13%10.39M |
Purchase of fixed assets | 26.76%-32.62M | -6.32%-171.93M | -37.15%-44.54M | -215.97%-161.71M | -325.15%-32.47M | 4.37%-51.18M | 79.40%-7.64M | 64.48%-53.52M | 51.62%-37.08M | -12.74%-150.67M |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --114K | ---- | ---- |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | -93.99%-10.94M | ---- | 77.24%-5.64M | ---- | 14.35%-24.78M |
Acquisition of subsidiaries | ---- | ---- | ---- | 98.82%-164.07K | ---- | ---13.85M | ---- | ---- | ---- | ---- |
Recovery of cash from investments | --150M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---50M | -1,071,328.57%-150M | ---- | ---14K | ---- | ---- | 10.27%-21.76M | ---- | -50.36%-24.24M | 82.02%-16.12M |
Other items in the investment business | -199.50%-57.8K | ---- | ---19.3K | -77.45%38.81M | ---- | 2,892.36%172.12M | ---- | -134.48%-6.16M | ---- | 443.97%17.88M |
Adjustment items of investment business | ---- | ---- | ---- | ---- | --5.65M | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 258.98%70.05M | -168.70%-317.67M | -98.51%-44.07M | -204.48%-118.23M | 23.44%-22.2M | 339.73%113.16M | 40.74%-28.99M | 68.59%-47.2M | 36.53%-48.93M | 17.80%-150.26M |
Net cash before financing | 47.21%406.85M | -211.18%-119.85M | 114.99%276.38M | -125.26%-38.52M | 242.32%128.56M | 7.29%152.45M | -37.11%37.55M | 172.28%142.09M | 116.80%59.72M | -137.09%-196.59M |
Cash flow from financing activities | ||||||||||
New borrowing | -4.06%55.64M | 1,037.12%573.36M | 480.00%58M | 1,700.80%50.42M | 266.67%10M | -53.33%2.8M | ---6M | -67.41%6M | ---- | -85.18%18.41M |
Refund | -66.18%-47M | -2,347.68%-455.79M | ---28.28M | -210.35%-18.62M | ---- | 55.77%-6M | ---- | 29.07%-13.56M | -2.55%-8.73M | -14.50%-19.12M |
Interest paid - financing | ---- | ---- | ---- | ---- | -53.82%-3.38M | -29.37%-8.14M | 42.36%-2.2M | 25.98%-6.29M | -585.79%-3.81M | -371.44%-8.5M |
Dividends paid - financing | 56.59%-3.27M | -39.48%-34.79M | 32.89%-7.53M | -92.73%-24.94M | -71.56%-11.22M | -10.09%-12.94M | 43.38%-6.54M | 58.46%-11.75M | ---11.55M | 44.20%-28.3M |
Absorb investment income | ---- | ---- | ---- | 486.55%35.19M | ---- | --6M | ---- | ---- | ---- | ---- |
Other items of the financing business | -126.72%-49.84M | 152.39%126.51M | ---21.99M | ---241.47M | ---- | ---- | ---- | 87.39%-14.41M | ---- | ---114.27M |
Net cash from financing operations | -21,792.98%-44.47M | 204.95%209.29M | 101.92%204.97K | -266.06%-199.42M | 27.64%-10.66M | 27.38%-54.48M | 58.29%-14.74M | 55.09%-75.02M | -186.33%-35.33M | -403.45%-167.06M |
Effect of rate | -99.94%2.33K | 213.21%4.18M | --3.62M | --1.33M | ---- | ---- | --125K | 1,005.15%1.07M | ---- | -70.78%97K |
Net Cash | 31.02%362.39M | 137.59%89.44M | 134.61%276.59M | -342.86%-237.94M | 416.70%117.89M | 46.09%97.97M | -6.43%22.82M | 118.44%67.07M | 106.63%24.38M | -1,205.02%-363.64M |
Begining period cash | 12.39%849.33M | -23.84%755.72M | -23.84%755.72M | 10.96%992.32M | 11.11%992.31M | 8.25%894.34M | 8.10%893.11M | -30.56%826.2M | -30.56%826.2M | -2.26%1.19B |
Cash at the end | 16.97%1.21B | 12.39%849.33M | -6.69%1.04B | -23.84%755.72M | 21.19%1.11B | 10.95%992.31M | 7.70%916.05M | 8.25%894.34M | 3.48%850.59M | -30.56%826.2M |
Cash balance analysis | ||||||||||
Bank deposits | ---- | ---- | ---- | ---- | ---- | --992.31M | ---- | ---- | ---- | ---- |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | --992.31M | ---- | ---- | ---- | ---- |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.